<DOC>
	<DOCNO>NCT01094899</DOCNO>
	<brief_summary>Assumptions Objectives : The work hypothesis : 1 - subject type 1 diabetes / type 2 , compare subject without diabetes risk osteopenia / abnormal bone structure foot ( calcaneus ankle ) lead bone deformity , fracture final stage Charcot foot . These anomaly favor presence peripheral neuropathy plasma level advance glycation end product higher diabetic subject without bone abnormality . The objective research evaluate anomaly quantitative qualitative bone foot ( calcaneus ankle ) use MicroScanner . In parallel whole body bone mineral density ( BMD ) calcaneal ultrasound perform measure bone mineral density realize clinical practice define population patient type 1 type 2 . These bone abnormality correlate presence peripheral neuropathy rate advance glycation end product proteins reference parameter chronic inflammation oxidative stress well understand pathophysiology target population risk . The importance study paramount management diabetic foot . Indeed moment deal primarily consequence diabetes impact bone bone deformity appear attendant disability risk recurrent infection area friction fragile environment . The ultimate goal target people diabetes abnormal bone subclinical take care avoid change bone deformity find way treat .</brief_summary>
	<brief_title>Abnormal Structure Bone Density Diabetes</brief_title>
	<detailed_description>The population study subject type 1 2 diabetes reveal fracture risk multiply 4 12 , especially shoulder , hip , ankle foot , compare population non-diabetic subject match age sex . If osteopenia ( decrease bone mineral density ) consistently associate fracture risk diabetic patient type 1 diabetes type 2 often bone mineral density comparable superior non diabetes subject . The various cause mention alteration quantity bone quality context chronic hyperglycemia disturbance interaction osteoblast ( cell form bone ) osteoclasts ( cell resorb bone ) , partly mediate system RANK / RANK-L / osteoprotegerin decrease bone formation increase osteolyses . The peripherical neuropathy , glycation protein ( modification proteins addition glucose ) receptor glycation proteins directly involve . At foot , change bone ( osteopenia decrease bone quality ) responsible deformation observe diabetic subject , result formation `` Charcot foot '' risk sores amputation major disability cause . Few study examine abnormality could find foot diabetic patient development deformity observe Charcot foot . One study look bone mineral density measure ultrasound Charcot foot contralateral foot subject type 1 type 2 compare subject diabetic Charcot foot . The author find decrease bone density measure ultrasound Charcot foot compare contralateral foot subject type 1 type 2 . Bone density contralateral foot reduce compare control subject diabetes subject type 1 diabetes patient type 2 diabetes . The link peripheral neuropathy clear . A second study woman type 1 diabetes premenopausal also find decrease bone density calcaneus measure ultrasound compare woman without diabetes . None study focus local structure bone . Yet may suspect hyperglycemia , include glycation protein may cause structural change bone diabetic subject . Previously , difficult understand structure bone non-invasive , MicroScanner develop Scanco company measure bone density trabecular architecture wrist ankle discrimination 42 micron . He minimal radiation ( 3 microsV ) allow resolution 80 micron . It already use osteopenic woman show significant difference term bone architecture woman fracture . Assumptions Objectives : The work hypothesis : 1 - subject type 1 diabetes / type 2 , compare subject without diabetes risk osteopenia / abnormal bone structure foot ( calcaneus ankle ) lead bone deformity , fracture final stage Charcot foot . These anomaly favor presence peripheral neuropathy plasma level advance glycation end product higher diabetic subject without bone abnormality . The objective research evaluate anomaly quantitative qualitative bone foot ( calcaneus ankle ) use MicroScanner . In parallel whole body BMD calcaneal ultrasound perform measure bone mineral density realize clinical practice define population patient type 1 type 2 . These bone abnormality correlate presence peripheral neuropathy rate advance glycation end product proteins reference parameter chronic inflammation oxidative stress well understand pathophysiology target population risk . The importance study paramount management diabetic foot . Indeed moment deal primarily consequence diabetes impact bone bone deformity appear attendant disability risk recurrent infection area friction fragile environment . The ultimate goal target people diabetes abnormal bone subclinical take care avoid change bone deformity find way treat .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Adult type 1 2 diabetes without neuropathy Pathology affect bone metabolism : abnormality phosphate metabolism prove biologically hepatic , chronic alcoholism renal insufficiency ( creatinine clearance &lt; 60 ml / min ) hyperthyroidism , intoxication active smoking , occlusive arteritis lower limb ( IPS &gt; IPS 1.2 &lt; 0.9 ) Treatment affect bone metabolism ( corticosteroids glitazones 3 month year bisphosphonates within 6 month ) Known HIV positive serology Progressive , inflammatory disease ( rheumatoid arthritis , ankylose spondylitis , bowel inflammatory )</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>diabetes</keyword>
	<keyword>osteopenia</keyword>
	<keyword>neuropathy</keyword>
	<keyword>foot</keyword>
	<keyword>AGE</keyword>
</DOC>